NAVCO PHARMACEUTICALS INC (NAV.CA) Stock Price, Quote, News and Overview
TSX-V:NAV - TSX Venture Exchange - CA63942R1091 - Common Stock - Currency: CAD
NAV.CA Quote, Performance and Key Statistics
TSX-V:NAV (4/21/2025, 7:00:00 PM)
0.01
0 (0%)
The current stock price of NAV.CA is 0.01 CAD. In the past month the price decreased by -50%. In the past year, price decreased by -50%.
About NAV.CA
Company Profile
Navco Pharmaceuticals, Inc. engages in the manufacture and research of nano-technology products and materials. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-11-05. The firm is engaged in developing and commercializing products to protect against viruses, bacteria, and infectious diseases. The company manufactures and researches nanotechnology products and materials using Computerized Nano-meter Algorithms (CNA). The firm's pipeline of applications is tailored to defend against microorganisms such as viruses, bacteria, fungi, and genetic manipulation tools such as clustered regularly interspaced short palindromic repeats (CRISPR). Its target markets include human health and personal skin care, household and institutional products and veterinary health. The company offers multiple main product lines, namely, an aerosol spray, hand sanitizer, hand cream, and nano BioGuard-Silver. The company also offers sublingual strips (the MunoStrips) infused with immune-boosting compounds to help maintain immune function and help support the body’s metabolism.
Company Info
NAVCO PHARMACEUTICALS INC
Suite 1500, 1055 West Georgia Street
Vancouver BRITISH COLUMBIA CA
Employees: 0
Company Website: http://www.navcopharma.com
Investor Relations: http://www.navcopharma.com/investor-information
Phone: 16043078290
NAVCO PHARMACEUTICALS INC / NAV.CA FAQ
What is the stock price of NAVCO PHARMACEUTICALS INC today?
The current stock price of NAV.CA is 0.01 CAD.
What is the ticker symbol for NAVCO PHARMACEUTICALS INC stock?
The exchange symbol of NAVCO PHARMACEUTICALS INC is NAV and it is listed on the TSX Venture Exchange exchange.
On which exchange is NAV.CA stock listed?
NAV.CA stock is listed on the TSX Venture Exchange exchange.
What is NAVCO PHARMACEUTICALS INC worth?
NAVCO PHARMACEUTICALS INC (NAV.CA) has a market capitalization of 570.70K CAD. This makes NAV.CA a Nano Cap stock.
How many employees does NAVCO PHARMACEUTICALS INC have?
NAVCO PHARMACEUTICALS INC (NAV.CA) currently has 0 employees.
Should I buy NAVCO PHARMACEUTICALS INC (NAV.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NAV.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NAV.CA, evaluating the profitability, health, valuation and growth aspects
- NAVCO PHARMACEUTICALS INC (NAV.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NAVCO PHARMACEUTICALS INC (NAV.CA) Sales and EPS estimates to see what analysts future expectations are.
- NAVCO PHARMACEUTICALS INC (NAV.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NAVCO PHARMACEUTICALS INC (NAV.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- NAVCO PHARMACEUTICALS INC (NAV.CA) Stock Chart to make your own analysis
- NAVCO PHARMACEUTICALS INC (NAV.CA) Latest news and press-releases to stay up to date.
Does NAVCO PHARMACEUTICALS INC (NAV.CA) stock pay dividends?
NAV.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of NAVCO PHARMACEUTICALS INC (NAV.CA)?
NAVCO PHARMACEUTICALS INC (NAV.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
NAV.CA Technical Analysis
NAV.CA Financial Highlights
Over the last trailing twelve months NAV.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 53.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2595.03% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |